Ping-Chih is a scientific advisor of Elixiron Immunotherapeutics. He currently serves as a tenure-track Assistant Professor of Department of Fundamental Oncology at University of Lausanne and Adjunct Scientist of Ludwig Center for Cancer Research Lausanne, Switzerland. Ping-Chih’s research interest is to decipher the metabolic regulation of immune responses in diseases from cancer to autoimmunity and to explore therapeutic interventions for metabolic reprogramming to restore appropriate immune function. He has numerous publications in the leading journals including Cell, Nature Immunology, Nature Medicine and Immunity. Ping-Chih has won many awards for his research in cancer immunology and holds several patents. Dr. Ho received his Ph.D. in Pharmacology from University of Minnesota and completed his postdoctoral training at Yale University.